Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Fatal infantile cytochrome C oxidase deficiency is a very rare mitochondrial disease characterized clinically by cardioencephalomyopathy resulting in death in infancy.
Biomarker and diagnostic research for fatal infantile encephalocardiomyopathy has been reported in the published literature.
No clinical trials have been registered for fatal infantile encephalocardiomyopathy.
1 publication has been identified in PubMed for fatal infantile encephalocardiomyopathy. Research spans Diagnostic / Biomarker (100%).
Wang S (2025). [PMID: 39266800](https://pubmed.ncbi.nlm.nih.gov/39266800/). *International journal of legal medicine*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:49 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center